149 results
POS AM
CANF
Can-Fite Biopharma Ltd
5 Apr 24
Prospectus update (post-effective amendment)
4:15pm
provisions customary for transactions of this nature. We also amended certain warrants to purchase up to an aggregate of 600,000 ADSs that were issued … in ADSs, and the nature of such interest and various other matters. ADS holders agree to provide such information reasonably requested by us pursuant
F-3/A
CANF
Can-Fite Biopharma Ltd
28 Dec 23
Shelf registration (foreign) (amended)
4:16pm
in such ADSs and regarding the identity of any other persons then or previously having a beneficial interest in ADSs, and the nature of such interest and various
F-3
CANF
Can-Fite Biopharma Ltd
12 Dec 23
Shelf registration (foreign)
4:15pm
or a beneficial interest in such ADSs and regarding the identity of any other persons then or previously having a beneficial interest in ADSs, and the nature
POS AM
su2t1 gqgl1qq67ja
1 Sep 23
Prospectus update (post-effective amendment)
4:16pm
F-3
a9zo7tt xv2he70i
1 Sep 23
Shelf registration (foreign)
4:15pm
6-K
EX-99.1
dbkc iyrku
31 Aug 23
Report of Foreign Private Issuer
7:12am
POS AM
allx2ntzswtkr
21 Apr 23
Prospectus update (post-effective amendment)
4:16pm
POS AM
ttf 41f46kipkotcj5
31 Mar 23
Prospectus update (post-effective amendment)
4:30pm
6-K
EX-99.1
8zs ujgvo3j
12 Sep 22
Report of Foreign Private Issuer
7:02am
POS AM
l4wcnfh
26 Aug 22
Prospectus update (post-effective amendment)
4:31pm
6-K
EX-99.1
hobke xh8
25 Aug 22
Report of Foreign Private Issuer
7:16am
POS AM
ygkxg beri08q7qr7q
25 Mar 22
Prospectus update (post-effective amendment)
4:30pm
424B3
clqozb2x x17y
14 Jan 22
Prospectus supplement
4:30pm
F-3
7mfb2727ys3nst7a1
7 Jan 22
Shelf registration (foreign)
4:31pm
D
9r6msaj0ok2jx
30 Dec 21
$10M in options / securities to be acquired, sold $10M, 1 investor
4:15pm
424B3
bhe1gh7xu
1 Sep 21
Prospectus supplement
4:30pm